| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-210 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-212 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-214 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-215 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-210 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18971180 | |
| miR-21 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-214* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-216a | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-216b | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-219 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-21 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 19633292 | |
| miR-216a | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-217 | Doxorubicin (Adriamycin) | small cell lung cancer | Sensitive | High | 20371173 | |
| miR-21 | Doxorubicin (Adriamycin) | esophageal cancer | Sensitive | High | 21248297 | |
| miR-21 | Doxorubicin (Adriamycin) | bladder cancer | Resistant | Low | 21468550 | |
| miR-21 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 21820606 | |
| miR-210 | Doxorubicin (Adriamycin) | ehrlich ascites tumor | Resistant | High | 21899346 | |
| miR-21 | Doxorubicin (Adriamycin) | chronic myeloid leukemia | Resistant | Low | 22957792 | |
| miR-21 | Doxorubicin (Adriamycin) | diffuse large B-cell lymphoma | Resistant | Low | 23275230 | |
| miR-21 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-2116 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-210 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-21 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 23527297 | |
| miR-214 | Doxorubicin (Adriamycin) | esophageal squamous cell carcinoma | Resistant | Low | 23721345 | |
| miR-21 | Doxorubicin (Adriamycin) | chronic myeloid leukemia | Resistant | Low | 23834154 | |
| miR-21 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 24606718 | |
| miR-214* | Doxorubicin (Adriamycin) | diffuse large B cell lymphoma (DLBCL) | Resistant | High | 24858372 | |
| miR-21 | Doxorubicin (Adriamycin) | glioblastoma | Resistant | Low | 25625875 | |
| miR-21 | Doxorubicin (Adriamycin) | glioblastoma | Resistant | Low | 25628933 | |
| miR-21* | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-210 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-211 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-214 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-215 | Doxorubicin (Adriamycin) | liver cancer | Resistant | High | 25698578 | |
| miR-218 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 25900794 | |
| miR-218 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | Low | 26261515 |